Open research questions in Herpesvirus Infections and Treatments
120 unresolved questions extracted from the limitations and future-work sections of 540 Herpesvirus Infections and Treatments papers in our library. Each links back to the study that raised it.
What the literature leaves open
Further studies are needed to establish the clinical effectiveness and safety of corticosteroids in HSVE, - More research is needed to understand the role of corticosteroids in alleviating edema and inflammatory injury, - Future studies should aim to address the limitations of the current evidence base
Adjunctive corticosteroids in herpes simplex virus encephalitis: a meta-analysis of randomized and observational studies · 2026 · DOIThe clinical effectiveness and safety of adjunctive corticosteroids in herpes simplex virus encephalitis are unknown. Prior studies have limitations and inconsistencies. There is a need for a comprehensive review of the current evidence.
Adjunctive corticosteroids in herpes simplex virus encephalitis: a meta-analysis of randomized and observational studies · 2026 · DOIConfirmation in external data sets with laboratory viral typing, antiviral treatment records, and mortality linkage is warranted.
Association of Herpes Simplex Virus Type-1 With Dementia Outcomes: Longitudinal Retrospective Cohort Study Using Real-World Electronic Health Record Data · 2026 · DOIEpidemiologic findings remain inconsistent, partly because many studies lack standardized designs for real-world data.
Association of Herpes Simplex Virus Type-1 With Dementia Outcomes: Longitudinal Retrospective Cohort Study Using Real-World Electronic Health Record Data · 2026 · DOIOBJECTIVE: Herpes zoster has been associated with immune and metabolic disturbances; however, its relationship with newly diagnosed Type 2 diabetes mellitus (T2DM) remains unclear.
Herpes zoster as a potential clinical marker of undiagnosed Type 2 diabetes in older adults: a retrospective cohort study · 2026 · DOIAbstract Background Herpetic keratitis (HK) is associated with frequent recurrences and vision-threatening sequelae, yet predictors of relapse remain poorly defined in children.
While the role of type 1 IFN in HSV-1 infection has been studied extensively, how IFN type 1 responses crosstalk with latency-associated transcript (LAT) in sensory neurons remains to be elucidated.
HSV-1 LAT promotes ocular diseases in the absence of type I IFN responses in sensory neurons · 2026 · DOIAlthough HZ vaccination is expected to reduce both HZ and its complications, comprehensive epidemiological data to guide vaccination strategies are scarce.
Epidemiology of herpes zoster and postherpetic neuralgia in Japan: analysis of a large-scale claims database · 2026 · DOIHowever, there are insufficient data on the transfer of amenamevir into breast milk among breastfeeding patients with RHS.
Transfer of amenamevir into breast milk in breastfeeding patients with recurrent herpes simplex: study protocol for a single-arm, open-label study · 2025 · DOIHowever, the heterogeneity and functionality of VZV-specific memory T cells in older individuals remain poorly understood.
Heterogeneity and functional diversity of VZV-specific memory CD4 T cells across age 9198 · 2025 · DOIThe necessity or the timing of booster vaccination warrants further investigation.
Real-world effectiveness of recombinant herpes Zoster vaccine: a retrospective, cohort study in Japan · 2025 · DOIAlthough aging is the most well-known risk factor for herpes zoster, little is known about the strength of the association between patient-related characteristics, including comorbidities, and their contribution to an increased risk of mortality, among patients hospitalized for HZ.
Comorbidities in hospitalized patients with herpes zoster: an Italian retrospective observational study in the years 2011–2023 · 2025 · DOIFactors such as sex, age at treatment initiation, coinfections, and pre-ART CD4 + T-cell count may influence this insufficient recovery.
The influence of extrinsic apoptosis gene expression on immunological reconstitution of male ART-treated PLHIV · 2025 · DOIThere is limited information about the role of co-infections in pathogenesis and the current prevalence of pathogens in North America.
Feline respiratory disease complex: insights into the role of viral and bacterial co-infections · 2024 · DOIThese results enriched the genome sequence data of ALV-K in Chinese geoducks, and laid the foundation for further research on the pathogenesis and prevention of ALV-K.
Detection and genetic diversity of subgroup K avian leukosis virus in local chicken breeds in Jiangxi from 2021 to 2023 · 2024 · DOINon-steroidal anti-inflammatory drugs (NSAIDs) are commonly used for pain relief and inflammation, though their potential role as KVE triggers remains uncertain.
Kaposi varicelliform eruption: an unusual presentation caused by varicella zoster virus in a healthy adult patient - a case report · 2024 · DOIAlthough SRLV infection and its impact on animal production are well established in the country, little is known about the circulating SRLV strains and their prevalence.
A Combined Approach for the Characterization of Small Ruminant Lentivirus Strains Circulating in the Islands and Mainland of Greece · 2024 · DOIThe lack of molecular diagnostics and advanced neuro-monitoring in resource-limited environments. The need for prompt antiviral intervention in pediatric patients with suspected herpes simplex encephalitis.
Navigating Diagnostic Constraints in Pediatric Herpes Simplex Encephalitis: Successful Empirical Acyclovir Therapy without PCR Confirmation · 2026 · DOIEarly computed tomography imaging is inherently unreliable; while typical images appear in 50 to 75 percent of cases, this typically image does not appear until after the first week of illness, limiting its utility in the acute phase.
Navigating Diagnostic Constraints in Pediatric Herpes Simplex Encephalitis: Successful Empirical Acyclovir Therapy without PCR Confirmation · 2026 · DOIThe need for evaluation of the impact of varicella immunization programs. The need for estimation of the relative vaccine effectiveness of two-dose versus single-dose regimens.
The Impact and Effectiveness of a Two-Dose Varicella Immunization Program Among School Children: Evidence from Quasi-experimental Analyses · 2026 · DOIThe functional role of the UL50 gene in duck enteritis virus is not well understood. There is a need for effective vaccines against duck enteritis virus.
Functional characterization of UL50 gene reveals its essential role in duck enteritis virus replication and pathogenesis · 2026 · DOISafety and challenge protection assays used limited sample sizes (n=10 for survival/temperature monitoring, n=5 for viral load), which may restrict statistical power and generalizability of protective efficacy findings.
Functional characterization of UL50 gene reveals its essential role in duck enteritis virus replication and pathogenesis · 2026 · DOIThe complexity of the HSV-1 genome. The difficulty of detecting R-loops and APOBEC enzyme binding. The need to develop therapeutic strategies to target viral R-loops.
The efficiency and genomic distribution of APOBEC-mediated mutations remain poorly understood. The role of R-loops in APOBEC3-mediated mutagenesis is not well understood.
There is a need for alternative strategies to treat economically significant viral diseases in cattle. The current treatment options for BVDV and BoHV-1 have limitations, including economic considerations.
Pampa biome plant extracts and flavonoids show antiviral activity against Bovine Herpesvirus and Bovine Viral Diarrhea Virus · 2026 · DOI
Most-cited papers in Herpesvirus Infections and Treatments
- Zika Virus Associated with Microcephaly · New England Journal of Medicine · 2016 · 2,492 citations
- A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults · New England Journal of Medicine · 2005 · 2,043 citations
- CULTIVATION OF PAPOVA-LIKE VIRUS FROM HUMAN BRAIN WITH PROGRESSIVE MULTIFOCAL LEUCOENCEPHALOPATHY · The Lancet · 1971 · 1,214 citations
- IDENTIFICATION OF HUMAN HERPESVIRUS-6 AS A CAUSAL AGENT FOR EXANTHEM SUBITUM · The Lancet · 1988 · 1,178 citations
- Herpes simplex virus infections · The Lancet · 2001 · 986 citations
- Trends in Herpes Simplex Virus Type 1 and Type 2 Seroprevalence in the United States · JAMA · 2006 · 812 citations
- Herpes simplex virus: global infection prevalence and incidence estimates, 2016 · Bulletin of the World Health Organization · 2020 · 721 citations
- Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines · MMWR Morbidity and Mortality Weekly Report · 2018 · 549 citations
- The Incidence of Herpes Zoster · Archives of Internal Medicine · 1995 · 485 citations
- Safety and Efficacy of High-Dose Intravenous Acyclovir in the Management of Neonatal Herpes Simplex Virus Infections · PEDIATRICS · 2001 · 475 citations
Most recent work
- Epidemiology of herpes zoster and postherpetic neuralgia in Japan: analysis of a large-scale claims database · BMC Infectious Diseases · 2026
- Recombinant shingles vaccination and the risk of cardiovascular events · Nature Medicine · 2026
- Herpes Zoster of the Maxillary Division of the Trigeminal Nerve Presenting as Endodontic Post-treatment Pain: Case Report and Review of the Literature · Journal of Endodontics · 2026
- Serological and molecular surveillance of infectious bovine rhinotracheitis in Kazakhstan · Frontiers in Veterinary Science · 2026
- Design and mechanistic insights into ZMF59/CpG: a complementary adjuvant system boosting immunity and safety in herpes zoster vaccines · Journal of Nanobiotechnology · 2026
- Bioactive Enhanced Adjuvant Chemokine Oligonucleotide Nanoparticles (BEACON) for Mucosal Vaccination Against Genital Herpes · bioRxiv · 2026
- Helicase-primase inhibitors as next-generation anti-HSV agents: from current clinical status to structure-activity relationships and patent coverage · Expert Opinion on Therapeutic Patents · 2026
- Global and regional trends in herpes simplex virus type 2 infection and genital ulcer disease · Communications Health · 2026
- Conserved assembly architecture of the essential herpesvirus packaging accessory factor · bioRxiv · 2026
- Structure and mechanism of the HSV-1 origin-binding protein UL9 · Journal of Virology · 2026
Find a gap in your own Herpesvirus Infections and Treatments sub-topic
This page shows what the Herpesvirus Infections and Treatments literature already flags as unresolved. To narrow it to your specific question, run the guided finder — it searches the gap library on demand and checks candidates against 250M+ OpenAlex works.
Open the Research Gap Finder →